annual retained earnings:
-$1.56B-$157.86M(-11.30%)Summary
- As of today (July 4, 2025), CLDX annual retained earnings is -$1.56 billion, with the most recent change of -$157.86 million (-11.30%) on December 31, 2024.
- During the last 3 years, CLDX annual retained earnings has fallen by -$411.62 million (-35.99%).
- CLDX annual retained earnings is now -53528.41% below its all-time high of -$2.90 million, reached on April 30, 1986.
Performance
CLDX Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
-$1.61B-$53.80M(-3.46%)Summary
- As of today (July 4, 2025), CLDX quarterly retained earnings is -$1.61 billion, with the most recent change of -$53.80 million (-3.46%) on March 31, 2025.
- Over the past year, CLDX quarterly retained earnings has dropped by -$178.85 million (-12.51%).
- CLDX quarterly retained earnings is now -55383.45% below its all-time high of -$2.90 million, reached on April 30, 1986.
Performance
CLDX quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
CLDX Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.3% | -12.5% |
| 3 y3 years | -36.0% | -37.9% |
| 5 y5 years | -53.5% | -56.8% |
CLDX Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.0% | at low | -33.8% | at low |
| 5 y | 5-year | -53.5% | at low | -55.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
CLDX Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | -$1.61B(+3.5%) |
| Dec 2024 | -$1.56B(+11.3%) | -$1.56B(+3.1%) |
| Sep 2024 | - | -$1.51B(+2.9%) |
| Jun 2024 | - | -$1.47B(+2.5%) |
| Mar 2024 | - | -$1.43B(+2.3%) |
| Dec 2023 | -$1.40B(+11.3%) | -$1.40B(+3.2%) |
| Sep 2023 | - | -$1.35B(+2.9%) |
| Jun 2023 | - | -$1.32B(+2.4%) |
| Mar 2023 | - | -$1.29B(+2.3%) |
| Dec 2022 | -$1.26B(+9.8%) | -$1.26B(+2.2%) |
| Sep 2022 | - | -$1.23B(+2.2%) |
| Jun 2022 | - | -$1.20B(+3.1%) |
| Mar 2022 | - | -$1.17B(+2.0%) |
| Dec 2021 | -$1.14B(+6.6%) | -$1.14B(+1.8%) |
| Sep 2021 | - | -$1.12B(+1.9%) |
| Jun 2021 | - | -$1.10B(+1.2%) |
| Mar 2021 | - | -$1.09B(+1.5%) |
| Dec 2020 | -$1.07B(+5.9%) | -$1.07B(+2.1%) |
| Sep 2020 | - | -$1.05B(+1.4%) |
| Jun 2020 | - | -$1.04B(+1.1%) |
| Mar 2020 | - | -$1.03B(+1.2%) |
| Dec 2019 | -$1.01B(+5.3%) | -$1.01B(+1.0%) |
| Sep 2019 | - | -$1.00B(+1.2%) |
| Jun 2019 | - | -$991.46M(+1.2%) |
| Mar 2019 | - | -$979.68M(+1.8%) |
| Dec 2018 | -$962.44M(+18.5%) | -$962.44M(+1.0%) |
| Sep 2018 | - | -$953.04M(+0.8%) |
| Jun 2018 | - | -$945.79M(+1.8%) |
| Mar 2018 | - | -$929.39M(+14.4%) |
| Dec 2017 | -$812.52M(+12.9%) | -$812.52M(+0.5%) |
| Sep 2017 | - | -$808.68M(+3.4%) |
| Jun 2017 | - | -$782.31M(+3.8%) |
| Mar 2017 | - | -$753.75M(+4.8%) |
| Dec 2016 | -$719.49M(+21.7%) | -$719.49M(+4.7%) |
| Sep 2016 | - | -$687.18M(+4.5%) |
| Jun 2016 | - | -$657.58M(+5.1%) |
| Mar 2016 | - | -$625.63M(+5.9%) |
| Dec 2015 | -$590.96M(+27.4%) | -$590.96M(+5.9%) |
| Sep 2015 | - | -$558.27M(+6.1%) |
| Jun 2015 | - | -$526.29M(+6.6%) |
| Mar 2015 | - | -$493.93M(+6.5%) |
| Dec 2014 | -$463.76M(+34.2%) | -$463.76M(+7.4%) |
| Sep 2014 | - | -$431.94M(+7.0%) |
| Jun 2014 | - | -$403.86M(+7.5%) |
| Mar 2014 | - | -$375.58M(+8.7%) |
| Dec 2013 | -$345.68M(+30.9%) | -$345.68M(+6.8%) |
| Sep 2013 | - | -$323.62M(+7.7%) |
| Jun 2013 | - | -$300.48M(+6.8%) |
| Mar 2013 | - | -$281.46M(+6.6%) |
| Dec 2012 | -$264.13M(+28.8%) | -$264.13M(+6.8%) |
| Sep 2012 | - | -$247.32M(+6.5%) |
| Jun 2012 | - | -$232.29M(+6.3%) |
| Mar 2012 | - | -$218.52M(+6.6%) |
| Dec 2011 | -$205.01M(+28.0%) | -$205.01M(+6.6%) |
| Sep 2011 | - | -$192.27M(+6.5%) |
| Jun 2011 | - | -$180.50M(+6.0%) |
| Mar 2011 | - | -$170.27M(+6.3%) |
| Dec 2010 | -$160.21M(+1.6%) | -$160.21M(-12.4%) |
| Sep 2010 | - | -$182.87M(+5.2%) |
| Jun 2010 | - | -$173.78M(+5.8%) |
| Mar 2010 | - | -$164.26M(+4.2%) |
| Dec 2009 | -$157.67M(+30.1%) | -$157.67M(+8.9%) |
| Sep 2009 | - | -$144.73M(+5.2%) |
| Jun 2009 | - | -$137.56M(+6.8%) |
| Mar 2009 | - | -$128.85M(+6.4%) |
| Dec 2008 | -$121.15M(+64.5%) | -$121.15M(+6.6%) |
| Sep 2008 | - | -$113.70M(+7.2%) |
| Jun 2008 | - | -$106.04M(+10.7%) |
| Mar 2008 | - | -$95.78M(+30.0%) |
| Dec 2007 | -$73.65M(-71.3%) | -$73.65M(-73.0%) |
| Sep 2007 | - | -$272.63M(+2.0%) |
| Jun 2007 | - | -$267.38M(+2.1%) |
| Mar 2007 | - | -$261.87M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | -$256.25M(+8.6%) | -$256.25M(+2.5%) |
| Sep 2006 | - | -$250.03M(+2.3%) |
| Jun 2006 | - | -$244.51M(+2.4%) |
| Mar 2006 | - | -$238.84M(+1.3%) |
| Dec 2005 | -$235.87M(+8.3%) | -$235.87M(+1.7%) |
| Sep 2005 | - | -$231.89M(+2.0%) |
| Jun 2005 | - | -$227.38M(+2.1%) |
| Mar 2005 | - | -$222.64M(+2.2%) |
| Dec 2004 | -$217.78M(+6.5%) | -$217.78M(+1.7%) |
| Sep 2004 | - | -$214.08M(+1.8%) |
| Jun 2004 | - | -$210.38M(+1.9%) |
| Mar 2004 | - | -$206.48M(+0.9%) |
| Dec 2003 | -$204.57M(+6.6%) | -$204.57M(+2.0%) |
| Sep 2003 | - | -$200.56M(+1.1%) |
| Jun 2003 | - | -$198.45M(+1.6%) |
| Mar 2003 | - | -$195.26M(+1.8%) |
| Dec 2002 | -$191.90M(+7.8%) | -$191.90M(+1.8%) |
| Sep 2002 | - | -$188.43M(+0.1%) |
| Jun 2002 | - | -$188.15M(+2.8%) |
| Mar 2002 | - | -$182.99M(+2.8%) |
| Dec 2001 | -$178.07M(+14.6%) | -$178.07M(+4.0%) |
| Sep 2001 | - | -$171.22M(+3.8%) |
| Jun 2001 | - | -$164.99M(+3.6%) |
| Mar 2001 | - | -$159.32M(+2.6%) |
| Dec 2000 | -$155.32M(+16.5%) | -$155.32M(+9.5%) |
| Sep 2000 | - | -$141.83M(+2.6%) |
| Jun 2000 | - | -$138.19M(+2.0%) |
| Mar 2000 | - | -$135.47M(+1.6%) |
| Dec 1999 | -$133.35M(+9.3%) | -$133.35M(+2.8%) |
| Sep 1999 | - | -$129.70M(+2.0%) |
| Jun 1999 | - | -$127.10M(+1.8%) |
| Mar 1999 | - | -$124.80M(+2.3%) |
| Dec 1998 | -$122.00M(+73.8%) | -$122.00M(+1.9%) |
| Sep 1998 | - | -$119.70M(+64.0%) |
| Jun 1998 | - | -$73.00M(+1.8%) |
| Mar 1998 | - | -$71.70M(+2.1%) |
| Dec 1997 | -$70.20M(+22.9%) | -$70.20M(+2.0%) |
| Sep 1997 | - | -$68.80M(+13.3%) |
| Jun 1997 | - | -$60.70M(+2.7%) |
| Mar 1997 | - | -$59.10M(+3.5%) |
| Dec 1996 | -$57.10M(+23.3%) | -$57.10M(+4.2%) |
| Sep 1996 | - | -$54.80M(+4.4%) |
| Jun 1996 | - | -$52.50M(+8.9%) |
| Mar 1996 | - | -$48.20M(+4.1%) |
| Dec 1995 | -$46.30M(+21.5%) | -$46.30M(+0.2%) |
| Sep 1995 | - | -$46.20M(+7.2%) |
| Jun 1995 | - | -$43.10M(+6.4%) |
| Mar 1995 | - | -$40.50M(+6.3%) |
| Dec 1994 | -$38.10M(+43.8%) | -$38.10M(+13.1%) |
| Sep 1994 | - | -$33.70M(+9.8%) |
| Jun 1994 | - | -$30.70M(+8.1%) |
| Mar 1994 | - | -$28.40M(+7.2%) |
| Dec 1993 | -$26.50M(+41.7%) | -$26.50M(+9.1%) |
| Sep 1993 | - | -$24.30M(+10.5%) |
| Jun 1993 | - | -$22.00M(+7.8%) |
| Mar 1993 | - | -$20.40M(+17.2%) |
| Dec 1992 | -$18.70M(+23.8%) | - |
| Oct 1992 | - | -$17.40M(+6.7%) |
| Jul 1992 | - | -$16.30M(+7.9%) |
| Apr 1992 | - | -$15.10M(+19.8%) |
| Apr 1992 | -$15.10M(+43.8%) | - |
| Jan 1992 | - | -$12.60M(-4.5%) |
| Oct 1991 | - | -$13.20M(+12.8%) |
| Jul 1991 | - | -$11.70M(+11.4%) |
| Apr 1991 | -$10.50M(+50.0%) | -$10.50M(+10.5%) |
| Jan 1991 | - | -$9.50M(+9.2%) |
| Oct 1990 | - | -$8.70M(+8.8%) |
| Jul 1990 | - | -$8.00M(+14.3%) |
| Apr 1990 | -$7.00M(+16.7%) | -$7.00M(-4.1%) |
| Jan 1990 | - | -$7.30M(+21.7%) |
| Apr 1989 | -$6.00M(+22.4%) | -$6.00M(+22.4%) |
| Apr 1988 | -$4.90M(+32.4%) | -$4.90M(+32.4%) |
| Apr 1987 | -$3.70M(+27.6%) | -$3.70M(+27.6%) |
| Apr 1986 | -$2.90M | -$2.90M |
FAQ
- What is Celldex Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Celldex Therapeutics?
- What is Celldex Therapeutics annual retained earnings year-on-year change?
- What is Celldex Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly retained earnings year-on-year change?
What is Celldex Therapeutics annual retained earnings?
The current annual retained earnings of CLDX is -$1.56B
What is the all time high annual retained earnings for Celldex Therapeutics?
Celldex Therapeutics all-time high annual retained earnings is -$2.90M
What is Celldex Therapeutics annual retained earnings year-on-year change?
Over the past year, CLDX annual retained earnings has changed by -$157.86M (-11.30%)
What is Celldex Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CLDX is -$1.61B
What is the all time high quarterly retained earnings for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly retained earnings is -$2.90M
What is Celldex Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CLDX quarterly retained earnings has changed by -$178.85M (-12.51%)